This document discusses the anesthetic considerations for head and neck oncosurgical procedures. It begins with an overview of the epidemiology of head and neck cancers and risk factors. It then discusses preoperative evaluation focusing on airway assessment, cardiovascular, pulmonary, and cancer-related complications. Intraoperative management focuses on securing the airway, fluid management, positioning, and complications related to specific procedures like thyroidectomy. Postoperative concerns include airway management, bleeding, hypocalcemia, and thyroid storm. Collaboration between the surgeon and anesthesiologist is emphasized for safe management.
Anesthetic Considerations In Head Neck Oncosurgical Management
1. D R N A Y A N A K U L K A R N I
C M C C
N A S I K
Anesthetic Considerations In Head
Neck
Oncosurgical Management
2. Objective
1/16/2016
dr nck cmcc nasik
2
At the end of this session the delegate should have a
fair idea of:
The peri-operative management of patients
undergoing surgery related to head and neck cancer
3. Head and neck cancer
1/16/2016
dr nck cmcc nasik
3
Worldwide 644k incidence and 350 k deaths
• 50,000 Americans are diagnosed with a head or neck
cancer (not including skin cancers that occur in the
head or neck)
~ 5 percent of all cancers in the US
– Majority are squamous cell carcinoma
• Survival rates have improved
– aggressive treatment
– early detection
– declining rates of tobacco and ETOH abuse
• The role of HPV
– The % of oropharyngeal cancers caused by human
papillomavirus (HPV) has increased
– 80% of oropharyngeal cancers are now caused by HPV
(industrialized countries)
4. Epidemiology
1/16/2016
dr nck cmcc nasik
4
Head and Neck Squamous cell carcinoma
(HNSCC), which constitutes the most common
upper aero digestive tract carcinomas.
Accounts for 3% of all cancers in the developed
countries like USA whereas in developing countries
like India it accounts for 30% of all cancers.
5. EPIDEMIOLOGIC TRENDS OF HEAD AND NECK
CANCERS
1/16/2016
dr nck cmcc nasik
5
Head and neck cancers are among the 10 most
common cancers globally.
In India, it accounts for one fourth of male cancers
and one tenth of female cancers (Yeole 2001).
Risk factors for head and neck cancers:
Consumption of alcohol,
Tobacco smoke,
smokeless tobacco,
alcohol,
marijuana use,
deficient diet,
Human Papilloma virus infection
6. General considerations for HNF surgery
1/16/2016
dr nck cmcc nasik
6
• Airway Management
– Anatomy (c-spine, +/- ROM, large tongue) – stridor
or hoarseness
– hx neck surgery, trauma, difficult intubation –
infections (epiglottitis, abscess)
– head/neck cancer radiation therapy
low threshold for fiberoptic
• backup plan
• sharing of airway with surgeon
• nasal intubation
8. Age
1/16/2016
dr nck cmcc nasik
8
Generally older patients
Cardiac- Co dec by 1% per yr after 30 yrs so ability
to in response to stress is diminished.
Respiratory – PaO2 by 0.5% per yr after 20 yrs, so
rapid hypoxemia esp if pt is smoker
Hepatic – drug clearance is impaired.
Renal- cr clearance also dec 1ml/min/yr after 20
yrs it means high sr creat may indicate underlying
severe impairment in clearance.
9. Cancer
1/16/2016
dr nck cmcc nasik
9
Chemo is given to cause tumor reduction.
It can result in affection of multiple systems in body
Due to cumulative dosages and drug toxicity:
Renal
Hepatic
Hematological / bone marrow suppression
Cardiac
Pulmonary
GI
11. Preoperative evaluation
Wyss, A. et. Al Am. J. Epidemiol. (2013) 178 (5): 679-690. doi:
10.1093/aje/kwt029
1/16/2016
dr nck cmcc nasik
11
Determine degree of compromise and risk
Focus preliminary exm on CVS , Airway and
Pulmonary systems.
– elderly comorbidities
– hx of smoking, EtOH
– Hx CAD, HTN, CRI, COPD
– Prior anesthesia hx
– preop testing imaging studies, PFTs, cardiac
and hepatic function
12. Preoperative
evaluation
1/16/2016
dr nck cmcc nasik
12
Increasing risk factors-
Obesity
age> 60
h/o smoking
PaCO2 > 45 mm Hg
Max breathing capacity of < 50% of predicted in PFT’s
Presence of pulmonary disease itself is predictor of
high incidence of peri- operative pulmonary
complications
Proper preop preperation in pt with pulmonary
disease can reduce periop morbidity and mortality
Bronchodilators,mucolytics,incentive
spirometry,abstinance from abusive agents, coughing
and deep breathing.
PFT- normalises by 8 wks.
Reduction in COHb- 12 hrs.
Stain M JAMA 211,787, 1970
22. Golden pearls
1/16/2016
dr nck cmcc nasik
22
Fluid management in Cancer surgeries.
Rehydration
maintainance
Replacement
Other goals-
Early ambulation
Chest PT
Recognise difficult airways and prepare for it.
23. General Considerations
1/16/2016
dr nck cmcc nasik
23
• Anesthetic Management –
-Smooth emergence
-Opioid based technique
-antiemetic prophylaxis
- OGT prior to emergence to empty stomach
+/-
– General with ETT vs. flexible ETT
24. General Considerations
1/16/2016
dr nck cmcc nasik
24
Adequate intra op/postop analgesia,
highly reflexogenic areas –
controlled hypotension –
decrease SBP< 100mmHg,
Keep MAP 60-70
Pt immobility muscle relaxation ?
25. Monitoring and access
1/16/2016
dr nck cmcc nasik
25
– ECG
– BP noninvasive vs. Arterial
– pulse Ox
– temp
– end tidal CO2
– RLN nerve monitoring current practice
– large bore IV, good access large bore IV, good
access
– positioning arms tucked, all access prior,
sticky pulse ox, nerve stimulator (where?)
26. Intraoperative
1/16/2016
dr nck cmcc nasik
26
- Protect eyes
– Cardiac function monitored
– Temp
–Head of bed can be elevated aids venous
drainage
– +/- Reinforced ETT
–Avoid drugs that stimulate sympathetic nervous
system
27. Options
1/16/2016
dr nck cmcc nasik
27
ETT with GA
Awake FOI
Awake DL and then assess intubation status
Recent IDL to predict level of difficulty
Trach with LA
28. Difficult mask ventilation
1/16/2016
dr nck cmcc nasik
28
Age>55
Presence of beard
BMI >26
Edentulous
h/o snoring
Massive jaw
Poor neck extension
Large tongue
Mandibular space
TMD
MMP
Neck
Pharyngeal pathology
Facial deformity
Facial dressings
Tumor growth on face
h/o difficult airway
Overbite
shape of palate
Inter incisor length
Cervical vertebral ROM
29. Intraop airway management
1/16/2016
dr nck cmcc nasik
29
Secure ETT prefer reinforced ETT
Assess Surgical field requirement accordingly fix
ETT
Trach as an when indicated
Prolonged reconstructions- keep head end elevated
to minimise supraglottic edema
Give dexamentasone
Minimise ETT movement
30. Extubation
1/16/2016
dr nck cmcc nasik
30
Keep tube exchanger at hand (bougie)
Jet ventilation /both
Preferably Keep lengthy and reconstructive
surgical pts intubated overnight.
Criterias for extubation-
Severity of pulmonary disease
Length and extent of surgery
Ability to protect airway
Ability to mobilize and remove secretions
Amount of residual respiratory depression from
residual anesthetic agents
31. Thyroidectomy
1/16/2016
dr nck cmcc nasik
31
Maintain adequate depth of anesthesia –
Remember DL is stimulant
– B-blockers are your friend
• Not particularly painful post-op.
– Complete reversal intact reflexes
– Recurrent Laryngeal Nerve Damage
• unilateral = hoarseness
• bilateral = aphonia and stridor
32. Thyroidectomy
1/16/2016
dr nck cmcc nasik
32
–Hematoma formation
–Hypoparathyroidism unintentional removal
of parathyroid glands.
(Chvostek’s and Trousseau’s)
–Awake vs Deep extubation
34. For Tracheostomy
1/16/2016
dr nck cmcc nasik
34
• Pre-op Assessment
– population usually includes: chronically ventilated
pts, pts having other procedure where trach is
required,
pts with upper airway obstruction (emergency)
– evaluate pt - ventilation settings
– airway, coexisting dx
– cardiac hx
– neuro assessment may be sedated
– In OR or Bedside +/- anesthesia
35. Intraop for Tracheostomy
1/16/2016
dr nck cmcc nasik
35
- For intubated pts GETA
–Airway compromised pts local anesthesia
– mucosal swelling
tissue fragility
• risk of tracheal mucosal separation and false passage
during trach
– Communicate with surgeon when using cautery in
the airway
– 100% O2 required before insertion of trach
36. Intraoperative Trach
1/16/2016
dr nck cmcc nasik
36
Trachea opened above cuff, ETT retracted slowly
with visualization of surgeon (communication),
do not remove all the way until trach in
place and +ETCO2 confirmation-
• Pneumothorax
• False passage
– recognize, no CO2,
PIP
absent breath sounds,
rigid bronchoscope and extra ETT available
37. Postoperative trach
1/16/2016
dr nck cmcc nasik
37
Transport to ICU with meds, equipment
– Trach tube displacement,
ETT and extra trach tube with stylet (obturator)
available
– Watch for bleeding
38. Anesthesia for ND
1/16/2016
dr nck cmcc nasik
38
• Radical, modified, or functional
• Usually performed with resection of primary lesion :
thyroid,
parathyroid,
tongue,
pharynx,
larynx, etc.
39. Preop considerations for ND
1/16/2016
dr nck cmcc nasik
39
– Airway decreased mobility
2°to radiation
• backup plan
• surgeon available surgeon available
– Resp COPD,
CO2 retention,
PFTs
– Cardiac: HTN, carotid artery stenosis
40. Intraoperative
1/16/2016
dr nck cmcc nasik
40
– Moderate decrease in BP,
- avoid adrenergic responses
– Muscle relaxant +/-
–Humidify gases reduce mucous plugging
–VAE occurs rarely
– Manipulation of carotid sinus bradycardia,
-- ↓ BP
41. Esp right side neck dissection
1/16/2016
dr nck cmcc nasik
41
• Right Radical Neck dissection -
• may cause prolonged QT interval which may progress
to ventricular arrhythmias and cardiac arrest
(due to interruption of cervical sympathetic outflow to
heart via right stellate ganglion)
43. Special considerations- minor procedures but not
so minor!!
1/16/2016
dr nck cmcc nasik
43
PEG insertion/ feeding gastrostomy in HN Ca pt on
RT- neck movement negligible,anatomical landmarks
not visible-
Difficult airway so may need FOI GA PEG
insertion.
DL in partial stridor pt-
Discuss possibility of Emergency trach with
relatives in dire conditions as life saving
measure.
ECA ligation post CT/RT-
difficult mask ventilation possibility must be
kept in mind.
44. At the end TEAM EFFORT wins
1/16/2016
dr nck cmcc nasik
44